Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Change in Accured Expenses (2022 - 2025)

Stoke Therapeutics has reported Change in Accured Expenses over the past 4 years, most recently at $8.9 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 308.54% year-over-year to $8.9 million; the TTM value through Dec 2025 reached $21.3 million, up 589.41%, while the annual FY2025 figure was $21.3 million, 589.41% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $8.9 million at Stoke Therapeutics, up from $4.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $8.9 million in Q4 2025 and troughed at -$4.4 million in Q2 2023.
  • A 4-year average of $1.1 million and a median of $705500.0 in 2022 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: crashed 677.39% in 2023 and later surged 751.67% in 2025.
  • Year by year, Change in Accured Expenses stood at $199000.0 in 2022, then crashed by 677.39% to -$1.1 million in 2023, then surged by 289.64% to $2.2 million in 2024, then soared by 308.54% to $8.9 million in 2025.
  • Business Quant data shows Change in Accured Expenses for STOK at $8.9 million in Q4 2025, $4.9 million in Q3 2025, and $2.8 million in Q2 2025.